// App-Quantinova.ai

: Longitudinal outcome of a restrictive therapeutic algorithm in Japanese patients with idiopathic membranous nephropathy

Researchers

Presenter

  • Nakazawa Daigo

Principal Investigators

  • Nishio Saori

  • Junya Yamamoto

  • Matsuoka Nao

  • Tatsuya Atsumi

Medical Centers

  • Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Nephrology

Disease

  • Membranous glomerulonephritis

  • Nephrotic syndrome

  • Renal insufficiency

  • Venous thrombosis

  • Hypertension

  • Renal disease

  • Focal segmental glomerulosclerosis

Biomarkers

  • Alpha-Actinin 4

  • Creatinine

  • Human albumin

Drug/Treatment

  • Methylprednisolone

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Cyclosporine eent

  • Prednisolone

  • Angiotensin II

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved